Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD301 Monoclonal Antibody (744812), Alexa Fluor™ 488
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA523645
Description
CD301 Monoclonal Antibody for Flow
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. The encoded type 2 transmembrane protein may function as a cell surface antigen. Two transcript variants encoding distinct isoforms have been identified for this gene.
Specifications
CD301 | |
Monoclonal | |
Alexa Fluor 488 | |
CLEC10A | |
CD301; CD301a; Clec10a; CLECSF13; CLECSF14; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 13 (macrophage-derived); C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 14 (macrophage-derived); C-type lectin domain family 10 member A; C-type lectin domain family 10, member A; C-type lectin superfamily member 14; HML; HML2; macrophage asialoglycoprotein-binding protein 1; macrophage galactose N-acetyl-galactosamine specific lectin 1; Macrophage galactose/N-acetylgalactosamine-specific lectin; Macrophage lectin 2; macrophage lectin 2 (calcium dependent); M-ASGP-BP-1; MGL; Mgl1; MMGL | |
Mouse | |
Protein A/G | |
RUO | |
10462 | |
4°C, store in dark, DO NOT FREEZE! | |
Liquid |
Flow Cytometry | |
744812 | |
Buffered saline solution with BSA and 0.09% sodium azide | |
Q8IUN9 | |
CLEC10A | |
Mouse myeloma cell line NS0-derived recombinant human CLEC10A/CD301 Gln61-His316. | |
100 Tests | |
Primary | |
Human | |
Antibody | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction